High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice

This publication has 27 references indexed in Scilit:

• Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates
  Journal of Virology, 2004
• A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice
  Journal of Virological Methods, 2004
• MODIFICATION OF DENGUE VIRUS STRAINS BY PASSAGE IN PRIMARY DOG KIDNEY CELLS: PREPARATION OF CANDIDATE VACCINES AND IMMUNIZATION OF MONKEYS
  The American Journal of Tropical Medicine and Hygiene, 2003
• Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli
  Biochemical and Biophysical Research Communications, 2003
• Expression and Purification of Dengue Virus Type 2 Envelope Protein as a Fusion with Hepatitis B Surface Antigen in Pichia pastoris
  Protein Expression and Purification, 2001
• Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine
  Journal of Virology, 2001
• Live attenuated tetravalent dengue vaccine
  Vaccine, 2000
• Dengue/Dengue Hemorrhagic Fever: The Emergence of a Global Health Problem
  Emerging Infectious Diseases, 1995
• Purification of Native Dengue-2 Viral Proteins and the Ability of Purified Proteins to Protect Mice
  The American Journal of Tropical Medicine and Hygiene, 1992
• Flavivirus Type-Specific Antigens Produced from Fusions of a Portion of the E Protein Gene with the Escherichia coli trpe Gene
  The American Journal of Tropical Medicine and Hygiene, 1991